Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
Oil States International
OIS
$496M
| $737K | ﹤0.01% |
137,500
-284,586
| -67% | -$1.26M |
2021 Q3
15 quarters
|
|
2652
DELISTED
MidWestOne Financial Group
MOFG
| $737K | ﹤0.01% |
25,600
+16,600
| +184% | +$469K |
2024 Q2
4 quarters
|
|
2653
Greenfire Resources
GFR
$1.53B
| $736K | ﹤0.01% |
165,000
-7,900
| -5% | -$37K |
2024 Q2
4 quarters
|
|
2654
Business First Bancshares
BFST
$1B
| $732K | ﹤0.01% |
29,700
-12,900
| -30% | -$303K |
2021 Q2
16 quarters
|
|
2655
DELISTED
Synchronoss Technologies
SNCR
| $732K | ﹤0.01% |
106,874
+3,900
| +4% | +$32.4K |
2018 Q4
26 quarters
|
|
2656
Outdoor Holding Co
POWW
$259M
| $730K | ﹤0.01% |
570,300
-59,200
| -9% | -$93.9K |
2023 Q1
9 quarters
|
|
2657
Tvardi Therapeutics
TVRD
$13.5M
| $729K | ﹤0.01% |
31,234
+1,724
| +6% | +$40.8K |
2023 Q1
9 quarters
|
|
2658
DELISTED
Repare Therapeutics
RPTX
| $727K | ﹤0.01% |
522,859
+224,198
| +75% | +$292K |
2021 Q2
16 quarters
|
|
2659
Cineverse
CNVS
$44.9M
| $726K | ﹤0.01% |
151,847
+67,700
| +80% | +$224K |
2024 Q2
4 quarters
|
|
2660
Biote Corp
BTMD
$33.6M
| $725K | ﹤0.01% |
180,394
+21,800
| +14% | +$80.4K |
2023 Q1
9 quarters
|
|
2661
DELISTED
Inotiv
NOTV
| $724K | ﹤0.01% |
397,954
+213,890
| +116% | +$464K |
2015 Q1
41 quarters
|
|
2662
DELISTED
Liberty Broadband Class A
LBRDA
| $724K | ﹤0.01% |
7,400
-65,200
| -90% | -$5.78M |
2023 Q4
6 quarters
|
|
2663
iShares Russell 1000 Growth ETF
IWF
$130B
| $722K | ﹤0.01% |
+6,800
| New | +$650K |
2025 Q2
0 quarters
|
|
2664
ProShares Short Dow30
DOG
$112M
| $721K | ﹤0.01% |
28,300
-25,300
| -47% | -$688K |
2025 Q1
1 quarter
|
|
2665
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.65B
| $716K | ﹤0.01% |
6,400
+2,100
| +49% | +$217K |
2024 Q2
4 quarters
|
|
2666
JPMorgan International Research Enhanced Equity ETF
JIRE
$10.9B
| $715K | ﹤0.01% |
+10,100
| New | +$674K |
2025 Q2
0 quarters
|
|
2667
DELISTED
Bridge Investment Group
BRDG
| $715K | ﹤0.01% |
71,400
-38,900
| -35% | -$363K |
2023 Q3
7 quarters
|
|
2668
Universal Electronics
UEIC
$69.8M
| $714K | ﹤0.01% |
107,823
-34,300
| -24% | -$210K |
2018 Q4
26 quarters
|
|
2669
Burford Capital
BUR
$782M
| $710K | ﹤0.01% |
49,800
+26,800
| +117% | +$350K |
2024 Q2
4 quarters
|
|
2670
Adicet Bio
ACET
$52M
| $704K | ﹤0.01% |
72,114
+21,445
| +42% | +$226K |
2022 Q4
10 quarters
|
|
2671
Delek US
DK
$4.72B
| $703K | ﹤0.01% |
33,200
-87,169
| -72% | -$1.46M |
2023 Q3
7 quarters
|
|
2672
Choiceone Financial
COFS
$487M
| $703K | ﹤0.01% |
24,500
-20,700
| -46% | -$588K |
2020 Q3
19 quarters
|
|
2673
Stock Yards Bancorp
SYBT
$2.36B
| $703K | ﹤0.01% |
8,900
+5,100
| +134% | +$373K |
2025 Q1
1 quarter
|
|
2674
Idaho Strategic Resources
IDR
$361M
| $700K | ﹤0.01% |
+53,500
| New | +$787K |
2025 Q2
0 quarters
|
|
2675
2x Bitcoin ETF
BITX
$1.26B
| $697K | ﹤0.01% |
+12,900
| New | +$620K |
2025 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.